Evidence map›Paper›PMID 28103860›Full record

ArticleBMC complementary and alternative medicine2017

Complementary and alternative medicine use among patients with cancer in Mongolia: a National hospital survey.

Buyadaa Oyunchimeg, Jung Hye Hwang, Mansoor Ahmed, Soojeung Choi, Dongwoon Han

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC complementary and alternative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. The Inhibitory Effect of KerraMedicina (Kaunas, Lithuania) · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Observational
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Buyadaa OyunchimegDepartment of Global Health and Development, Graduate school, Hanyang University, Seoul, South Korea.
Jung Hye HwangDepartment of Global Health and Development, Graduate school, Hanyang University, Seoul, South Korea.
Mansoor AhmedInstitute of Health Services Management, Hanyang University College of Medicine, Seoul, South Korea.
Soojeung ChoiDepartment of Global Health and Development, Graduate school, Hanyang University, Seoul, South Korea.
Dongwoon HanDepartment of Global Health and Development, Graduate school, Hanyang University, Seoul, South Korea. dwhan@hanyang.ac.kr.ORCID http://orcid.org/0000-0003-0206-8976

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundComplementary and alternative medicine (CAM) use is popular in former Soviet Central Asian countries including Mongolia. However, no studies are available on CAM use among patients with cancer in countries of this region. The aim of this research is to describe the prevalence and patterns of CAM use by patients with cancer in Mongolia.

methodsA cross-sectional study was conducted using data from 482 cancer patients attending the National Cancer Center in Mongolia from September 2015 to February 2016. The survey instrument included 25 questions regarding CAM used, factors associated with use of CAM, cancer-related characteristics, and participants' socio-demographic profile.

resultsAmong 482 respondents (response rate, 95.6%), 47.9% reported using one or more CAM modalities. Products of animal origin were the most popular modalities of CAM, followed by herbal products. Half of the users used CAM while receiving conventional treatment of cancer. Among users, only 29% discussed the CAM use with their doctors. Female gender, younger age, higher education, shorter disease duration, and prior use of CAM were significantly associated with CAM use.

conclusionsCAM appears to be widely accepted by patients with cancer in Mongolia. The findings support the urgent need for further in-depth study into commonly used oral CAM products and their potential effects on health of patients with cancer in Mongolia. High prevalence of CAM use among cancer patients in our study warrants further studies in other countries of Central Asia.

Indexed as

HospitalsAdultComplementary TherapiesCross-Sectional StudiesFemaleHealth SurveysHumansMaleMiddle AgedMongoliaNeoplasmsCancerComplementary and alternative medicineConventional treatmentMongoliaPredictors of CAM use

Identifiers

PMID28103860
PMCPMC5244576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.